Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss

v3.8.0.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenues:        
Collaboration revenue $ 9,565,890 $ 0 $ 26,572,397 $ 0
Total revenues 9,565,890 0 26,572,397 0
Operating expenses:        
Research and development 11,165,150 4,825,421 32,308,786 13,770,371
General and administrative 2,449,382 2,069,447 7,406,591 6,883,708
Total operating expenses 13,614,532 6,894,868 39,715,377 20,654,079
Loss from operations (4,048,642) (6,894,868) (13,142,980) (20,654,079)
Other income (expense):        
Interest income 258,623 33,640 648,103 94,995
Interest expense (189,041) (17,500) (473,354) (52,500)
Other (expense) income (21,318) 11,818 (71,779) 1,645
Total other income 48,264 27,958 102,970 44,140
Net loss (4,000,378) (6,866,910) (13,040,010) (20,609,939)
Other comprehensive income (loss):        
Net unrealized (losses) gains on marketable securities (455) (9,999) (16,948) 12,885
Comprehensive loss $ (4,000,833) $ (6,876,909) $ (13,056,958) $ (20,597,054)
Net loss per share, basic and diluted $ (0.13) $ (0.31) $ (0.46) $ (0.96)
Weighted average shares outstanding used in computing net loss per share, basic and diluted 30,004,037 22,410,702 28,104,199 21,527,993